Cibc Private Wealth Group, LLC Biomarin Pharmaceutical Inc Transaction History

Cibc Private Wealth Group, LLC

$52.7 Billion
Q4 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 596 shares of BMRN stock, worth $40,677. This represents 0.0% of its overall portfolio holdings.

Number of Shares

596

Previous 363 64.19%

Holding current value

$40,677

Previous $25,000 56.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$61.93 - $70.49 $14,429 - $16,424	233 Added 64.19%	596 $39,000
Q2 2024 Aug 09, 2024	SELL	$74.43 - $92.22 $13,769 - $17,060	-185 Reduced 33.76%	363 $29,000
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $45,927 - $54,252	548 New	548 $47,000
Q4 2022 Jun 01, 2023	BUY	$80.93 - $108.63 $765,031 - $1.03 Million	9,453 New	9,453 $978,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $3.86 Million - $5.18 Million	-47,709 Reduced 83.46%	9,453 $978,000
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $420,084 - $495,654	-5,113 Reduced 8.21%	57,162 $4.85 Million
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $357 - $434	5 Added 0.01%	62,275 $5.16 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $12,761 - $14,329	169 Added 0.27%	62,270 $5.2 Million
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $14,721 - $17,865	-197 Reduced 0.32%	62,101 $4.69 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $1.29 Million - $1.61 Million	17,798 Added 40.0%	62,298 $5.46 Million
Q3 2020 Nov 03, 2020	BUY	$71.87 - $131.03 $3.2 Million - $5.83 Million	44,500 New	44,500 $3.39 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $2.26 Million - $3.54 Million	-28,460 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $7,137 - $9,685	100 Added 0.35%	28,460 $2.41 Million
Q4 2019 Jan 30, 2020	BUY	$64.27 - $86.37 $304,061 - $408,616	4,731 Added 20.02%	28,360 $2.4 Million
Q3 2019 Oct 16, 2019	BUY	$67.4 - $85.11 $1,280 - $1,617	19 Added 0.08%	23,629 $1.59 Million
Q2 2019 Jul 31, 2019	BUY	$80.35 - $93.9 $3,133 - $3,662	39 Added 0.17%	23,610 $2.02 Million
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $63,655 - $74,556	756 Added 3.31%	23,571 $2.09 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $469 - $528	5 Added 0.02%	22,815 $2.21 Million
Q2 2018 Aug 02, 2018	BUY	$76.01 - $99.03 $111,734 - $145,574	1,470 Added 6.89%	22,810 $2.15 Million
Q1 2018 May 17, 2018	SELL	$77.67 - $92.63 $507,418 - $605,151	-6,533 Reduced 23.44%	21,340 $1.73 Million
Q4 2017 Feb 12, 2018	BUY	$80.76 - $95.13 $517,913 - $610,068	6,413 Added 29.88%	27,873 $2.49 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.73 Million - $2.04 Million	21,460	21,460 $2 Million

Others Institutions Holding BMRN

# of Institutions

626

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.7B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Biomarin Pharmaceutical Inc Transaction History